Maternal Health
Credibility 94
Extended-Release vs Sublingual Buprenorphine in Pregnancy Through 12 Months Post Partum: A Randomized Clinical Trial.
May 1, 2026 · JAMA internal medicine
Key takeaway
A new study suggests that for pregnant Black women dealing with opioid use disorder, a weekly shot of buprenorphine may help more than daily pills to stay off opioids during pregnancy. This is good news because it could mean fewer risks for mothers and babies.
Why this matters for our communities
Research in maternal health helps close long-standing gaps in how Black and African American families are studied, diagnosed, and cared for. Use findings like this one to start informed conversations with your care team — not as a substitute for personal medical advice.
More in Maternal Health
December 29, 2026Comparing two posttraumatic stress disorder screening approaches to improve health outcomes in pregnant black women: a comparative effectiveness trial protocol.Read December 17, 2026Investigating racial differences in the receipt of antenatal interventions prior to periviable delivery.Read December 17, 2026Psychometric properties of the City Birth Trauma Scale in Black trauma-exposed women.Read